chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: F
Vaccine: FLUN3
Symptoms: Dysgeusia
Clinical narrative: A non-serious spontaneous report of metallic taste in mouth for two weeks has been received from a health professional concerning a 11-year-old female, subsequent to FLUMIST. Neither relevant past medical history nor concomitant medications had been reported for this patient. The patient received FLUMIST in 2009-2010 season. After receiving FLUMIST in 2010, the patient had metallic taste in his mouth for two weeks. The outcome of the event was recovered.
Age: 78.0
Sex: M
Vaccine: TD
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Physician reports being paged on Sat. 2/25/12 by patient with swelling, redness and warmth at site of injection. On 2/27/12 patient updates office that symptoms have resolved.
Age: 0.56
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Abnormal behaviour, Computerised tomogram head normal, Cyanosis, Febrile convulsion, Full blood count increased
Clinical narrative: Within 24 hours of receiving vaccines, child developed high fever (up to 103 degrees F), hands turned blue & child had short periods of altered behavior. Dx - febrile seizure.
Age: 0.56
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Pyrexia, Streptococcus test negative, Urine analysis normal
Clinical narrative: Within 24 hours of receiving vaccines, child developed high fever (up to 103 degrees F), hands turned blue & child had short periods of altered behavior. Dx - febrile seizure.
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, HEPA, HPV4
Symptoms: Death
Clinical narrative: None at time of service. Pt. expired 2-26-12.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Cellulitis, Erythema, Induration, Pain, Skin warm
Clinical narrative: Aching pain, swelling, warmth & erythema. Onset 2/25/12 - no relieving factors i e: cold compresses TYLENOL/ibup. Seen in office 3d after vaccine given Rx KEFLEX to cover cellulitis, induration marked with pen on 2/25/12 as instructed by on call nurse area 2/27/12 progressed - .5in.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Swelling
Clinical narrative: Aching pain, swelling, warmth & erythema. Onset 2/25/12 - no relieving factors i e: cold compresses TYLENOL/ibup. Seen in office 3d after vaccine given Rx KEFLEX to cover cellulitis, induration marked with pen on 2/25/12 as instructed by on call nurse area 2/27/12 progressed - .5in.
Age: 4.0
Sex: F
Vaccine: DTP, IPV, MMR
Symptoms: Crying, Fatigue, Learning disability, Lip swelling, Petit mal epilepsy
Clinical narrative: Crying for hours, fatigue, hives all over body, high fever, petit mal seizures (staring), swollen face & lips.
Age: 4.0
Sex: F
Vaccine: DTP, IPV, MMR
Symptoms: Pyrexia, Staring, Swelling face, Urticaria
Clinical narrative: Crying for hours, fatigue, hives all over body, high fever, petit mal seizures (staring), swollen face & lips.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Abortion induced, Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Information has been received from a physician concerning a baby fetus at 14 weeks of LMP a 30 year old mother with a history of irregular menses who on 25-APR-2011 was vaccinated with a first dose of MMR II (Lot # 665427/0667Z). Concomitant therapy included vitamins (unspecified). On an unspecified date experienced an elective abortion at 14 weeks of gestation. (LMP: 16-APR-2011). It was reported that the fetus experienced Turner's syndrome. At the time of reporting, the patient's outcome was unknown. Turner's syndrome was considered to be congenital anomaly by the physician The mother's experience has been captured in WAES 1106USA02225). Additional information has been requested.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site induration, Injection site pain, Injection site warmth, Local reaction
Clinical narrative: Local reaction - deltoid pain w/ mild warmth, induration.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion induced, Blood test, Maternal exposure during pregnancy, No adverse event, Ultrasound foetal
Clinical narrative: Information has been received from a medical assistant, for GARDASIL, a Pregnancy Registry product, concerning a 12 year old female patient with no pertinent medical history or drug reactions/allergies who on 07-MAR-2011 was vaccinated with a dose of GARDASIL (lot # 662299/1099Y, exp unspecified). There was no concomitant medication. Subsequently the patient found out she was pregnant on 01-APR-2011. She took blood work, results not was reported. There was no adverse reaction reported. There was no treatment given. The patient did not seek medical attention. Follow-up information has been received from a healthcare worker. It was reported that the patient chose to have an elective abortion on 11-JUN-2011. It was reported that her LMP was 02-MAR-2011. It was reported that she had a fetal ultrasound on 15-APR-2011 that revealed cardiac activity with a gestational age of 6/2 to 7 weeks. No fetal anomalies were noted in the ultrasound report. Upon internal review, elective abortion was determined to be an other important medical event. Additional information is not expected.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Ultrasound scan normal
Clinical narrative: Information has been received from a medical assistant, for GARDASIL, a Pregnancy Registry product, concerning a 12 year old female patient with no pertinent medical history or drug reactions/allergies who on 07-MAR-2011 was vaccinated with a dose of GARDASIL (lot # 662299/1099Y, exp unspecified). There was no concomitant medication. Subsequently the patient found out she was pregnant on 01-APR-2011. She took blood work, results not was reported. There was no adverse reaction reported. There was no treatment given. The patient did not seek medical attention. Follow-up information has been received from a healthcare worker. It was reported that the patient chose to have an elective abortion on 11-JUN-2011. It was reported that her LMP was 02-MAR-2011. It was reported that she had a fetal ultrasound on 15-APR-2011 that revealed cardiac activity with a gestational age of 6/2 to 7 weeks. No fetal anomalies were noted in the ultrasound report. Upon internal review, elective abortion was determined to be an other important medical event. Additional information is not expected.
Age: 58.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Chills, Headache, Hyperhidrosis, Induration, Injected limb mobility decreased
Clinical narrative: Client received vaccine at 10:45 am. Started experiencing soreness and swelling in (R) deltoid area at 3:00pm same day. Started experiencing chills & sweating at 6-7 pm. Couldn't get warm. Swelling extended down (R) arm & below (R) breast, the next day. Wasn't able to use arm yesterday. Can raise arm to shoulder area today. Reports slight headache and body aches. 90 x 120 cm induration on (R) arm distal to injection site. Injection site looks clear.
Age: 58.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site pain, Injection site swelling, Pain, Swelling
Clinical narrative: Client received vaccine at 10:45 am. Started experiencing soreness and swelling in (R) deltoid area at 3:00pm same day. Started experiencing chills & sweating at 6-7 pm. Couldn't get warm. Swelling extended down (R) arm & below (R) breast, the next day. Wasn't able to use arm yesterday. Can raise arm to shoulder area today. Reports slight headache and body aches. 90 x 120 cm induration on (R) arm distal to injection site. Injection site looks clear.
Age: 59.0
Sex: F
Vaccine: TD
Symptoms: Axillary pain, Insomnia, Lymphadenopathy, Mobility decreased, Oedema peripheral
Clinical narrative: Right arm. The pain in my under arm was painful. I also could not sleep. It felt like it was swollen. I could not put arm all the way down by my side or it would hurt. Right arm upper. This also happen with a flu shot back in 2010. When I took it. I don't know why this is happening. Left arm upper. It seems to be settling in the lymph nodes.
Age: 59.0
Sex: F
Vaccine: TD
Symptoms: Pain
Clinical narrative: Right arm. The pain in my under arm was painful. I also could not sleep. It felt like it was swollen. I could not put arm all the way down by my side or it would hurt. Right arm upper. This also happen with a flu shot back in 2010. When I took it. I don't know why this is happening. Left arm upper. It seems to be settling in the lymph nodes.
Age: 0.2
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Emotional distress, Injection site pain, Injection site swelling
Clinical narrative: Napped to 130p then awoke, inconsolable, swelling and tenderness at injection sites. Reseen in office at 345p. TYLENOL given and observed for 30 minutes.
Age: 0.36
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Computerised tomogram normal, Convulsion, Electroencephalogram normal, Lumbar puncture normal, Nuclear magnetic resonance imaging normal
Clinical narrative: Cluster of seizures.
Age: 1.4
Sex: M
Vaccine: DTAP, HEP, VARCEL
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness/warmth R. thigh in area of varicella vaccine --> no treatment necessary.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, FLU3, PNC13, RV5
Symptoms: Emotional distress, Fatigue, Irritability
Clinical narrative: Child was fussy and very tired for over 24 hours. Mom stated he would lay on her and couldn't calm him down. Temperature was 99.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site cellulitis, Tenderness
Clinical narrative: Cellulitis (L) arm - erythema, tenderness. Treatment Clindamycin 300mg TID x 7 days.
Age: 16.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Dyskinesia, Erythema, Hemiparesis, Hypoaesthesia
Clinical narrative: Streaks up her arm 1 day after vaccine, felt weak on (L) side & numb; no fever or viral symptoms & lasted 3 days. Her left leg was not moving right x3 days.
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Allergy to metals, Clostridium test positive, Culture positive, Flow cytometry, Full blood count normal
Clinical narrative: Initial case was received from the scientific literature on 15 February 2012. The following is verbatim from the article: "The patient was born at 41 weeks gestation via Cesarean section after an uncomplicated pregnancy. The umbilical cord separated at age 1 month. Routine immunizations at birth, 1 and 2 months of age were uneventful. During the 6-month visit, a violaceous nodule was noted on the right thigh at the site of the 4-month PENTACEL injection. This was thought to be a hematoma, and the 6-month vaccines were given as usual. One week later, the patient returned to the pediatrician because the nodule had become fluctuant and expressed a purulent exudate. An abscess was suspected, so empiric antibiotic therapy with sulfamethoxazole-trimethoprim was started. Culture was negative. Two weeks after the 6-month visit, the patient continued to have drainage from the first nodule and was noted to have fever and two new nodules at the sites of the 6-month PENTACEL and PREVNAR injections. These two nodules were incised and drained, and one culture grew Clostridium perfringens. Antibiotic coverage was changed to a 2-week course of clindamycin. When the child presented to dermatology at 8 months of age, the sites of these vaccine reactions demonstrated atrophic dimpling with central hyperpigmentation. An immunodeficiency evaluation was performed because of these recurrent abscess-like lesions. Laboratory tests consisted of complete blood count, immunoglobulins, lymphocyte subsets, and nitroblue-tetrazolium test. Findings were all negative or normal. Leukocyte adhesion deficiency was investigated using flow cytometry, which confirmed the presence CD18, CD11b, and CD11c on the cell surface of the patient's granulocytes. An alternate explanation was sought, and aluminum allergy was considered. Patch testing of varying concentrations of aluminum chloride and controls was performed in a protocol similar to that previously published. Aluminum chloride 3.5%, 1.7%, and 0.35% dilutions were made from commercially obtained aluminum chloride 35% in water. Application was performed using Finn chambers coated with polypropylene. Controls of water and petrolatum were placed. Patches were read at 48 and 96 hours. There was no reaction at 48 hours. A reaction was seen at 96 hours and was graded as 3+ to 3.5%, 2+ to 1.7%, and 1+ to 0.35% aluminum chloride dilutions. The patient had positive reactions at the sites containing aluminum chloride and negative reactions at the control sites. A healthy control was tested with the same concentration of aluminum chloride to exclude the possibility of an irritant reaction to the tested solution and had no reaction. Based on these findings, the patient was diagnosed with contact allergy to aluminum." Documents held by sender: None.
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Immunoglobulins normal, Immunology test normal, Incisional drainage, Injection site abscess, Injection site atrophy
Clinical narrative: Initial case was received from the scientific literature on 15 February 2012. The following is verbatim from the article: "The patient was born at 41 weeks gestation via Cesarean section after an uncomplicated pregnancy. The umbilical cord separated at age 1 month. Routine immunizations at birth, 1 and 2 months of age were uneventful. During the 6-month visit, a violaceous nodule was noted on the right thigh at the site of the 4-month PENTACEL injection. This was thought to be a hematoma, and the 6-month vaccines were given as usual. One week later, the patient returned to the pediatrician because the nodule had become fluctuant and expressed a purulent exudate. An abscess was suspected, so empiric antibiotic therapy with sulfamethoxazole-trimethoprim was started. Culture was negative. Two weeks after the 6-month visit, the patient continued to have drainage from the first nodule and was noted to have fever and two new nodules at the sites of the 6-month PENTACEL and PREVNAR injections. These two nodules were incised and drained, and one culture grew Clostridium perfringens. Antibiotic coverage was changed to a 2-week course of clindamycin. When the child presented to dermatology at 8 months of age, the sites of these vaccine reactions demonstrated atrophic dimpling with central hyperpigmentation. An immunodeficiency evaluation was performed because of these recurrent abscess-like lesions. Laboratory tests consisted of complete blood count, immunoglobulins, lymphocyte subsets, and nitroblue-tetrazolium test. Findings were all negative or normal. Leukocyte adhesion deficiency was investigated using flow cytometry, which confirmed the presence CD18, CD11b, and CD11c on the cell surface of the patient's granulocytes. An alternate explanation was sought, and aluminum allergy was considered. Patch testing of varying concentrations of aluminum chloride and controls was performed in a protocol similar to that previously published. Aluminum chloride 3.5%, 1.7%, and 0.35% dilutions were made from commercially obtained aluminum chloride 35% in water. Application was performed using Finn chambers coated with polypropylene. Controls of water and petrolatum were placed. Patches were read at 48 and 96 hours. There was no reaction at 48 hours. A reaction was seen at 96 hours and was graded as 3+ to 3.5%, 2+ to 1.7%, and 1+ to 0.35% aluminum chloride dilutions. The patient had positive reactions at the sites containing aluminum chloride and negative reactions at the control sites. A healthy control was tested with the same concentration of aluminum chloride to exclude the possibility of an irritant reaction to the tested solution and had no reaction. Based on these findings, the patient was diagnosed with contact allergy to aluminum." Documents held by sender: None.
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Injection site discharge, Injection site discolouration, Injection site nodule, Lymphocyte count normal, Purulent discharge
Clinical narrative: Initial case was received from the scientific literature on 15 February 2012. The following is verbatim from the article: "The patient was born at 41 weeks gestation via Cesarean section after an uncomplicated pregnancy. The umbilical cord separated at age 1 month. Routine immunizations at birth, 1 and 2 months of age were uneventful. During the 6-month visit, a violaceous nodule was noted on the right thigh at the site of the 4-month PENTACEL injection. This was thought to be a hematoma, and the 6-month vaccines were given as usual. One week later, the patient returned to the pediatrician because the nodule had become fluctuant and expressed a purulent exudate. An abscess was suspected, so empiric antibiotic therapy with sulfamethoxazole-trimethoprim was started. Culture was negative. Two weeks after the 6-month visit, the patient continued to have drainage from the first nodule and was noted to have fever and two new nodules at the sites of the 6-month PENTACEL and PREVNAR injections. These two nodules were incised and drained, and one culture grew Clostridium perfringens. Antibiotic coverage was changed to a 2-week course of clindamycin. When the child presented to dermatology at 8 months of age, the sites of these vaccine reactions demonstrated atrophic dimpling with central hyperpigmentation. An immunodeficiency evaluation was performed because of these recurrent abscess-like lesions. Laboratory tests consisted of complete blood count, immunoglobulins, lymphocyte subsets, and nitroblue-tetrazolium test. Findings were all negative or normal. Leukocyte adhesion deficiency was investigated using flow cytometry, which confirmed the presence CD18, CD11b, and CD11c on the cell surface of the patient's granulocytes. An alternate explanation was sought, and aluminum allergy was considered. Patch testing of varying concentrations of aluminum chloride and controls was performed in a protocol similar to that previously published. Aluminum chloride 3.5%, 1.7%, and 0.35% dilutions were made from commercially obtained aluminum chloride 35% in water. Application was performed using Finn chambers coated with polypropylene. Controls of water and petrolatum were placed. Patches were read at 48 and 96 hours. There was no reaction at 48 hours. A reaction was seen at 96 hours and was graded as 3+ to 3.5%, 2+ to 1.7%, and 1+ to 0.35% aluminum chloride dilutions. The patient had positive reactions at the sites containing aluminum chloride and negative reactions at the control sites. A healthy control was tested with the same concentration of aluminum chloride to exclude the possibility of an irritant reaction to the tested solution and had no reaction. Based on these findings, the patient was diagnosed with contact allergy to aluminum." Documents held by sender: None.
Sex: M
Vaccine: DTAPIPVHIB, PNC
Symptoms: Pyrexia, Skin test positive
Clinical narrative: Initial case was received from the scientific literature on 15 February 2012. The following is verbatim from the article: "The patient was born at 41 weeks gestation via Cesarean section after an uncomplicated pregnancy. The umbilical cord separated at age 1 month. Routine immunizations at birth, 1 and 2 months of age were uneventful. During the 6-month visit, a violaceous nodule was noted on the right thigh at the site of the 4-month PENTACEL injection. This was thought to be a hematoma, and the 6-month vaccines were given as usual. One week later, the patient returned to the pediatrician because the nodule had become fluctuant and expressed a purulent exudate. An abscess was suspected, so empiric antibiotic therapy with sulfamethoxazole-trimethoprim was started. Culture was negative. Two weeks after the 6-month visit, the patient continued to have drainage from the first nodule and was noted to have fever and two new nodules at the sites of the 6-month PENTACEL and PREVNAR injections. These two nodules were incised and drained, and one culture grew Clostridium perfringens. Antibiotic coverage was changed to a 2-week course of clindamycin. When the child presented to dermatology at 8 months of age, the sites of these vaccine reactions demonstrated atrophic dimpling with central hyperpigmentation. An immunodeficiency evaluation was performed because of these recurrent abscess-like lesions. Laboratory tests consisted of complete blood count, immunoglobulins, lymphocyte subsets, and nitroblue-tetrazolium test. Findings were all negative or normal. Leukocyte adhesion deficiency was investigated using flow cytometry, which confirmed the presence CD18, CD11b, and CD11c on the cell surface of the patient's granulocytes. An alternate explanation was sought, and aluminum allergy was considered. Patch testing of varying concentrations of aluminum chloride and controls was performed in a protocol similar to that previously published. Aluminum chloride 3.5%, 1.7%, and 0.35% dilutions were made from commercially obtained aluminum chloride 35% in water. Application was performed using Finn chambers coated with polypropylene. Controls of water and petrolatum were placed. Patches were read at 48 and 96 hours. There was no reaction at 48 hours. A reaction was seen at 96 hours and was graded as 3+ to 3.5%, 2+ to 1.7%, and 1+ to 0.35% aluminum chloride dilutions. The patient had positive reactions at the sites containing aluminum chloride and negative reactions at the control sites. A healthy control was tested with the same concentration of aluminum chloride to exclude the possibility of an irritant reaction to the tested solution and had no reaction. Based on these findings, the patient was diagnosed with contact allergy to aluminum." Documents held by sender: None.
Age: 75.0
Sex: F
Vaccine: PPV
Symptoms: Rash erythematous
Clinical narrative: Administration PNEUMOVAX into right upper arm and patient developed a 4-5 cm raised erythematous patch which decreased over 24 hours rt 02/21/2012 Fluticasone nasal spray 2 sprays into each nostril daily - start 02/21/2012 Aspirin 81 mg by mouth daily - start 02/21/2012 Atenolol 25 mg by mouth daily - start 02/21/2012 Enoxaparin sodium 40 mg subcutaneously daily - start 02/21/2012 Acetaminophen 650 mg by mouth every 4 hours as needed - start 02/20/2012.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Rash erythematous
Clinical narrative: The patient got a PNEUMOVAX shot in her right upper arm and developed a 4-5 cm raised erythematous patch which decreased over 24 hours. She has since been discharged.
Age: 0.35
Sex: F
Vaccine: PNC13, RV5, VARCEL
Symptoms: Drug administered to patient of inappropriate age, No adverse event, Wrong drug administered
Clinical narrative: Pt. was accidentally given varicella immunization instead of PENTACEL immunization. Pt. has had no ill effects from varicella immunization.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Blood pressure increased, Dizziness, Dyspnoea, Eye pruritus
Clinical narrative: On 2/17/12 at 13:05 pt received Tdap, w/in 30 min. pt reports HA. On 2/18/12 at 2 am pt woke w/ difficulty breathing: shaky feeling, noted itchy on neck/ears. At 8 AM noted difficulty breathing - assessed B/P 157/90, HR 130's decreased O2 85% paramedics called noted wheezing pt give - Albuterol and taken to ED breathing improved. On 2/20/12 pt states feeling dizzy & weak, follow up on 2/21/12 pt improved. Pt can be reached for more details - OK to leave message.
Age: 34.0
Sex: F
Vaccine: TDAP
Symptoms: Headache, Heart rate increased, Nervousness, Oxygen saturation decreased, Wheezing
Clinical narrative: On 2/17/12 at 13:05 pt received Tdap, w/in 30 min. pt reports HA. On 2/18/12 at 2 am pt woke w/ difficulty breathing: shaky feeling, noted itchy on neck/ears. At 8 AM noted difficulty breathing - assessed B/P 157/90, HR 130's decreased O2 85% paramedics called noted wheezing pt give - Albuterol and taken to ED breathing improved. On 2/20/12 pt states feeling dizzy & weak, follow up on 2/21/12 pt improved. Pt can be reached for more details - OK to leave message.
Age: 0.5
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Pyrexia, Seizure like phenomena
Clinical narrative: Went to the ER for seizure-like activity. Also had a fever.
Age: 26.0
Sex: F
Vaccine: FLUX, TTOX
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Was given tetanus vaccine on December 02/11 AM. Later that day at home my left arm was sore and aching, couldn't move arm. It been over 2 months and still hurts. Cannot function arm properly.
Age: 41.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Erythema, Pain in extremity, Pyrexia, Skin warm, White blood cell count increased
Clinical narrative: Lt arm red, warm to touch, painful to light touch.
Age: 41.0
Sex: M
Vaccine: FLU3, PPV, FLU3, PPV
Symptoms: Erythema, Pyrexia, Skin warm, Tenderness, White blood cell count increased
Clinical narrative: Lt arm red, warm to touch, painful to light touch.
Age: 0.22
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Cyanosis, Unresponsive to stimuli
Clinical narrative: Patient at daycare, took nap at 12 Noon still sleeping at 2pm; found blue and unresponsive at 3pm.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Cough, Urticaria
Clinical narrative: Hives, coughing starting 2/16/12 pm. Dr 2/17/12 ER 2/18/12 ER 2/19/12 & hospital. Dismissed hosp 2/21/12. Tx. BENADRYL, prednisone, PEPCID, albuterol inhaler.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue
Clinical narrative: 2/22/12 Patient came back to report that she experienced 72 hours of undue fatigue that began 24 hours after vaccinated. Complete recovery.
Age: 82.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: The patient received PNEUMOVAX IM Lot L89AA Manufactured by Merck on 2-12-12, and on 2-13-12 the patient was readmitted for cellulitis at the injection site.
Age: 1.03
Sex: F
Vaccine: PNC13, VARCEL
Symptoms: Body temperature increased, Erythema, Oedema, Rash erythematous, Skin warm
Clinical narrative: Grandma was undressing child last night & noticed redness, edema & skin hot to touch. Also noticed small red raised bumps under diaper band & on (R) leg. Temp at this visit 100.2.
Age: 44.0
Sex: M
Vaccine: HEPAB, YF
Symptoms: Cellulitis, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Symptoms at site of yellow fever vaccine inj. Seen in our office 1/17/12 for vaccines for trip. Returned for other vaccines on 1/25/12. At that time noted redness & swelling & warmth at yellow fever injection site. Referred to PCP. On 2/16/12 returned for further immunizations. Stated PCP had treated him for cellulitis. No redness/swelling/warmth currently.
Age: 1.42
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Pain, Vomiting
Clinical narrative: Soon after receiving vaccines pt began with profuse vomiting & pain.
Age: 1.02
Sex: M
Vaccine: FLU3, HEPA, MMR, PNC13, VARCEL
Symptoms: Rash macular
Clinical narrative: 6 days after MMR, developed a macular rash. On exam: About 25 scattered macules over entire body.
Age: 28.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Erythema, Pain, Skin warm, Swelling
Clinical narrative: Red, warm, swollen, pain.
Age: 4.0
Sex: F
Vaccine: HEP, PNC13
Symptoms: Injection site swelling
Clinical narrative: Swelling left arm, and not tender.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Erythema, Fatigue, Swelling face, Urticaria
Clinical narrative: Waited 15 min in office after vac. administered -> no reaction. Went home, was very tired & went to sleep. When she awoke her face was red & swollen. Trunk & extremities covered in hives. No diff. breathing. Given BENADRYL by mom.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, VARCEL
Symptoms: Electroencephalogram normal, Immediate post-injection reaction, Nuclear magnetic resonance imaging normal, Syncope
Clinical narrative: Had episode of syncope immediately following vaccination with HPV. Six weeks later had 2 more episodes syncope with nl MRI nl EEG.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Abnormal behaviour, Aggression, Agitation, Fatigue, Somnolence
Clinical narrative: 3d after vaccine was was fatigued & sleepy & agitated. On 4th or 5th day, she became aggressive with raising voice to her parents, abrupt & didn't want to be around her family members. This was a sudden change.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Dyskinesia
Clinical narrative: Within 5-10 minutes of vaccine pt slumped forward in chair & feet jerked once. Pt brought back into room, laid down supine position. Pulse, BP checked (normal). Auscultated heart & lungs & watched her balance & walk without problems.
Age: 83.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Patient states injection site was red morning of 02/27/12 and became very itchy as time passed. As of 02/28/12 is still red/itchy no better/no worse. She will contact her MD 2/29/12 if not better.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Delirium, Injection site induration, Injection site pain, Injection site swelling, Pallor
Clinical narrative: 1st pain at injection site, then approximately 21 hours later fever to 105 degrees F, delirium, induration at injection site to 12 cm with blanching extending up to iliac crest & down to knee; fever persisted for 3 days & pain/swelling of injection site lasted 1 week.
Age: 4.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Pyrexia
Clinical narrative: 1st pain at injection site, then approximately 21 hours later fever to 105 degrees F, delirium, induration at injection site to 12 cm with blanching extending up to iliac crest & down to knee; fever persisted for 3 days & pain/swelling of injection site lasted 1 week.
Age: 0.57
Sex: F
Vaccine: HIBV, IPV, PNC, RV5, DT, HIBV, IPV, PNC13, RV5
Symptoms: Hypotonia, Pyrexia
Clinical narrative: Had the above shots. Later that night was limp for 30 minutes. Developed a fever the next day.
Age: 0.57
Sex: F
Vaccine: HIBV, IPV, PNC, RV5, DT, HIBV, IPV, PNC13, RV5
Symptoms: Decreased activity, Pyrexia, Screaming, Staring
Clinical narrative: Had the above shots. Later that night was limp for 30 minutes. Developed a fever the next day.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling, redness of left arm shoulder to elbow.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: ZOSTAVAX vaccine was administered on 2/25/12. Patient said symptoms began 2/26/12 in the morning. She reported redness, swelling & itchiness at the injection site. She did not report any other AE. Did not have any trouble breathing or rash on any other part of body. Patient was told to take a dose of BENADRYL & follow-up with PCP if no improvement.
Age: 58.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Injected limb mobility decreased, Injection site pain, Periarthritis
Clinical narrative: Complained of severe pain (without movement and unable to raise arm due to pain) upper left arm following Tdap injection. Denied redness, swelling or warmth at site. After 48 hours, pain improved some, then has persisted to present. Pain is slowly resolving. Client described as "frozen shoulder" with feeling of joint pain. Client called to report event 12 days afterwards, and advised to seek medical evaluation. Seen per Dr the next week. No diagnosis given. Only treatment Ibuprofen as needed.
Age: 1.09
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Rash generalised
Clinical narrative: Palpable rash over entire body.
Age: 1.03
Sex: M
Vaccine: HIBV, MMR, PNC13
Symptoms: Injection site erythema, Injection site induration, Injection site rash, Injection site warmth, Skin irritation
Clinical narrative: The patient presents with skin irritation.  The symptoms began 3 days ago.   Two weeks ago pt had his shots.  3 days ago in the same area pt had shots he develpoed rash like bumps then the area doubled in size over night and became red, hot, and hard. Reviewed above no fever, hx of egg allergy.  Scratching when pants off, immunizations. 11 days ago immunized 11 days ago in area of rxn. No other exposures
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Patient reports experiencing soreness at injection site as well as a red area around the injection site about the size of a dollar bill folded in half.  Patient also report heat in the area of redness.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Noticed swelling of thigh at injection site. Larger than 3" diameter. Hot to touch. Taken to hospital.
Age: 0.71
Sex: M
Vaccine: DTAPIPVHIB, FLU3, PNC13
Symptoms: Acute disseminated encephalomyelitis, Acute respiratory failure, Mobility decreased, Nuclear magnetic resonance imaging brain abnormal, Pyrexia
Clinical narrative: Fever, patient unable to move extremities and the body below the neck, acute respiratory failure.
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Local reaction, Malaise, Oedema peripheral, Pain in extremity
Clinical narrative: Pt with localized arm swelling, redness, pain, and overall malaise.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Erythema, Headache, Lethargy, Rash
Clinical narrative: ZOSTAVAX SQ 2/24/12 --> presented to occupational health cc: raised area 4 cm diameter center 6" x 4" width area of erythema. C/O HA lethargic joint aches.
Age: 1.09
Sex: M
Vaccine: DTAPHEPBIP, FLU3, HEPA, HIBV, MMR, MNQ
Symptoms: Pyrexia, Rash generalised
Clinical narrative: Fever, body rash.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Oedema peripheral, Pruritus, Skin test, Swelling face, Urticaria
Clinical narrative: Itching and swelling to face hand and feet. Developed hives.
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Blood test abnormal, Injection site pain, Pain, Rheumatoid arthritis
Clinical narrative: Persistent throbbing pain on R arm (where received the shot) radiating to L arm and down to hips.
Age: 23.0
Sex: F
Vaccine: FLU3
Symptoms: Injected limb mobility decreased, Pain, Swelling
Clinical narrative: Pain, swelling, difficulty moving left arm for 17 days.
Age: 0.96
Sex: F
Vaccine: HIBV
Symptoms: Irritability, Vomiting
Clinical narrative: Mom called to report that pt was fussy and had vomited once or twice about six hours after vaccine Hib given.  Mom advised to monitor hydration and give Tylenol for pain/fever.
Age: 30.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Asthenia, Dizziness, Headache, Lethargy, Nausea
Clinical narrative: Fever, severe headache, dizziness, nausea, weakness, lethargy.
Age: 30.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Pyrexia
Clinical narrative: Fever, severe headache, dizziness, nausea, weakness, lethargy.
Age: 0.51
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Rash generalised, Skin exfoliation, Skin warm
Clinical narrative: Rash on temples.  In 24 hours the rash had spread from head to foot.  Rash acted like a burn, hot to the touch, no fever, 1 wk and 1 day after shot skin peeling.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient called this morning complaining that injection site had become swollen, red, and very itchy. The adverse reaction started after injection and lasted several days. Patient reports that the reaction is improving and going away.
Age: 14.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Dyspnoea
Clinical narrative: 5 mins after HPV vaccine was administered pt felt light headed and stated having difficulty breathing. Had pt sit for 15 mins.
Age: 14.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Dizziness, Dyspnoea, Mycobacterium tuberculosis complex test
Clinical narrative: 5 mins after HPV vaccine was administered pt felt light headed and stated having difficulty breathing. Had pt sit for 15 mins.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Fatigue, Induration, Pain, Skin warm
Clinical narrative: Patient experienced redness, soreness, hardness, it was raised and approximately 4 inches in diameter. Warm to touch. Experienced some fatigue.
Age: 0.35
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Injection site swelling, Joint swelling, Urticaria
Clinical narrative: Hives & swelling hip to knee (R) thigh P.O. BENADRYL swelling. Resolved 12 22 11.
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Intra-uterine death, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US013526 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to a female patient (age not specified). She was vaccinated with H1N1 (manufacturer and batch number: unknown) between 01 Oct 2009 and 28 Feb 2010. She was pregnant at the time of vaccination. On an unspecified date the patient had an intrauterine fetal death. It was reported that it could not be categorized as spontaneous abortion or stillbirth because the gestational age was not known. Authors concluded that the pregnant women who were vaccinated with H1N1 vaccination with inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes. The most common pregnancy specific adverse event was spontaneous abortion (SAB) and stillbirth, and more than a third of women who experienced SAB had at least one risk factor (advance maternal age). Seventy two percent of women who had stillbirth had at least one risk factor or had a pathological finding in the fetus or placenta, suggesting factor other than vaccination that may be contributed to the fetal demise. This suggested that women with higher risk were overrepresented in VAERS database.
Sex: U
Vaccine: FLUX(H1N1)
Symptoms: Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Case number PHHY2012US013523 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to a neonate born to a pregnant female (see linked case: PHHY2012US013487) on an unspecified date. The mother was vaccinated with pandemic influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational period between 01 Oct 2009 to 28 Feb 2010. The neonate had intraparenchymal hemorrhage. The outcome of the event was not reported. Authors concluded that the pregnant women who were vaccinated with 2009 H1N1 vaccination with inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes. The most common pregnancy specific adverse event was spontaneous abortion (SAB) and stillbirth, and more than a third of women who experienced SAB had at least one risk factor (advance maternal age). Seventy two percent of women who had stillbirth had at least one risk factor and had a pathological finding in the fetus or placenta, suggesting factor other than vaccination that may be contributed to the fetal demise. This suggested that women with higher risk were overrepresented in VAERS database.
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Foetal disorder, Maternal exposure during pregnancy
Clinical narrative: Case number PHHY2012US013454 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to a fetus (unknown gestational age) of a pregnant female patient. At an unknown gestational period the pregnant female patient was vaccinated with H1N1 (manufacturer and batch number: unknown) between 01 Oct 2009 and 28 Feb 2010 (see linked case: PHHY2012US013454). On an unspecified date fetal adverse event of tachycardia was noted. The outcome of the event was not reported. The causality of the case was not reported. The authors stated that the VAERS database search did not reveal any clustering of spontaneous abortions, still births or congenital anomalies. Authors concluded that the pregnant women who were vaccinated with H1N1 with inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes.
Age: 23.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Foetal disorder, Maternal exposure during pregnancy, Ultrasound antenatal screen abnormal
Clinical narrative: Case number PHHY2012US013372 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to a 23-year-old female patient. She was vaccinated with H1N1 (manufacturer and batch number: unknown) between 01 Oct 2009 and 28 Feb 2010. She was pregnant and was at 19 weeks of gestation at the time of vaccination. The cleft lip was first detected during a prenatal ultrasound examination at 22 weeks gestation. On an unspecified date she delivered a baby with a congenital anomaly of cleft lip (see linked case: PHHY2012US013388). The author's stated that, because cleft lip is embryologically determined during the first trimester of pregnancy, it is implausible to consider vaccination at 19 weeks gestation as a possible causative agent. Authors concluded that the pregnant women who were vaccinated with H1N1 vaccination with inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes. The most common pregnancy specific adverse event was spontaneous abortion (SAB) and stillbirth, and more than a third of women who experienced SAB had at least one risk factor (advance maternal age). Seventy two percent of women who had stillbirth had at least one risk factor or had a pathological finding in the fetus or placenta, suggesting factor other than vaccination that may be contributed to the fetal demise. This suggested that women with higher risk were overrepresented in VAERS database.
Age: 23.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Maternal exposure during pregnancy, Neonatal disorder, Ultrasound antenatal screen abnormal
Clinical narrative: Case number PHHY2012US013388 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to an infant born to a 23-year-old female patient (see linked case: PHHY2012US013372), who was vaccinated with pandemic influenza vaccine (manufacturer and batch number: unknown) at 19 weeks of gestation between 01 Oct 2009 to 28 Feb 2010. The cleft lip was first detected during a a prenatal ultrasound examination at 22 weeks gestation. On an unspecified date the baby was born with a congenital anomaly cleft lip. The author's stated that, because cleft lip is embryologically determined during the first trimester of pregnancy, it is implausible to consider vaccination at 19 weeks gestation as a possible causative agent.
Age: 72.0
Sex: M
Vaccine: FLU3
Symptoms: Skin ulcer
Clinical narrative: Case number PHEH2012US003974 is an initial spontaneous report received from a nurse on 14 Feb 2012. This case refers to a 72-year-old male patient. He was vaccinated with FLUVIRIN (batch number: 1100501) intramuscularly at a dose of 0.5ml on 28 Oct 2011. On 30 Oct 2011 he began to develop open sores all over his body. The outcome was reported as ongoing at the time of this report.
Age: 1.13
Sex: M
Vaccine: FLU3, HEPA, MMR, VARCEL
Symptoms: Hypersensitivity, Rash
Clinical narrative: Truncal rash started 12 days after immunization (hep A, varicella, flu, MMR). Mother brought child to office visit with health care provider. Immunizations given on 2/7/12. Office visit is was 12/21/12. Diagnosed as hypersensitivity MMR reaction possibly delayed.
Age: 24.0
Sex: M
Vaccine: TTOX
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 74.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site oedema, Injection site pruritus, Injection site urticaria, Injection site warmth
Clinical narrative: (R) arm developed edema warmth hives & itching from elbow to shoulder began few hours after the vaccine. Better with CLARITIN.
Age: 0.52
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC
Symptoms: Urticaria
Clinical narrative: Urticaria 48 hours post vaccination on 9/12/11. Was given BENADRYL.
Age: 16.0
Sex: M
Vaccine: FLU3, HPV4, MNQ
Symptoms: Asthenia, Culture throat, Dyspnoea, Feeling cold, Hypoaesthesia
Clinical narrative: Felt numb, freezing, felt like he could not breathe, very weak, sore over night.
Age: 16.0
Sex: M
Vaccine: FLU3, HPV4, MNQ
Symptoms: Pain, Streptococcus test
Clinical narrative: Felt numb, freezing, felt like he could not breathe, very weak, sore over night.
Age: 11.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Face oedema, Lip swelling, Ocular hyperaemia, Rash generalised
Clinical narrative: He had lip swelling, facial edema & entire body rash. He also had eye redness.
Age: 12.0
Sex: F
Vaccine: FLUN3
Symptoms: Influenza
Clinical narrative: This is a verbatim narrative as reported on website, accessed on 28 July 2011. According to the web site these reports were from FDA VAERS. "FLUMIST problem was reported on Nov 13, 2007. Female patient, child 12 years of age, was vaccinated with FLUMIST on Nov 13, 2007. "Client had flu symptoms approximately 2 weeks after the FLUMIST administration, and has continued with these to the present. Is being treated by the primary physician with TAMIFLU." None. None noted per mother's hx. Patient recovered."
Age: 28.0
Sex: M
Vaccine: FLUN3
Symptoms: Cough, Nasal congestion, Oropharyngeal pain, Pyrexia, Swelling
Clinical narrative: This is a verbatim narrative as reported on web site, accessed on 28 July 2011. According to the web site these reports were from FDA VAERS. "FLUMIST problem was reported on Dec 03, 2007. Male patient, 28 years of age, was vaccinated with FLUMIST on Dec 03, 2007. "Nasal congestion, nasal swelling, fever, sore throat, coughing." None. "allergic to BENADRYL, I contact solution, tape adhesive". Patient recovered."
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Blood pressure abnormal, Chest X-ray abnormal, Cold sweat, Computerised tomogram head, Computerised tomogram normal
Clinical narrative: Passed out immediately, but awoke after several seconds. Had cold clammy skin. Blood pressure would not regulate. After half an hour began vomiting. Small red spots began to develop on lower abdomen. Spots developed higher and higher until they reached the midpoint of my neck, and then began to recede. Was rushed to the hospital where it took me roughly 3 hours before my blood pressure reached a level deemed safe to for discharge. Over the next two nights, trying to sleep, I found it difficult to breathe. In the weeks following this event I became forgetful and rather simple minded. It was abnormal for me, because I have a very analytical mind and frequently find myself thinking of all sorts of things. I wish I knew the extend of how that shot affected me.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Dyspnoea, Electrocardiogram abnormal, Immediate post-injection reaction, Loss of consciousness, Memory impairment
Clinical narrative: Passed out immediately, but awoke after several seconds. Had cold clammy skin. Blood pressure would not regulate. After half an hour began vomiting. Small red spots began to develop on lower abdomen. Spots developed higher and higher until they reached the midpoint of my neck, and then began to recede. Was rushed to the hospital where it took me roughly 3 hours before my blood pressure reached a level deemed safe to for discharge. Over the next two nights, trying to sleep, I found it difficult to breathe. In the weeks following this event I became forgetful and rather simple minded. It was abnormal for me, because I have a very analytical mind and frequently find myself thinking of all sorts of things. I wish I knew the extend of how that shot affected me.